Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Vertex Pharmaceuticals (VRTX) reachead $495.29 at the closing of the latest trading day, reflecting a +1.42% change compared to its last close. We recently published a list of the 11 Best Pharma ...

After hours: March 13 at 6:33:34 PM EDT Loading Chart for BRKR ...

After hours: March 10 at 7:59:37 p.m. EDT Loading Chart for VRTX ...

The sketches on this page have been generously donated by leading engineering offices. They represent a broad range of scenarios where freehand drawings are the preferred tool of the engineer. Thanks ...